Description

This paper investigates the technological readiness of consumer electronics for the measurement of vital signs, cardiovascular / metabolic and infectious diseases and shows how these technologies can promote self-care of consumers. We propose a 3-dimensional framework which characterizes diseases according to their burden of disease, their potential for self-care and the readiness of enabling technologies in consumer devices. With the evaluation of current technologies we show that a growing number of medical conditions, especially lifestyle-related cardiovascular diseases, can be identified and monitored easily, precisely and non-invasively by consumers. Based on a 3D-self-care framework we propose strategies for three target groups: Consumers should focus on lifestyle-related diseases, healthcare payers should focus on research funding for technologies addressing high burden diseases and technology developers should focus on diseases that can be supported by close-to-market technolog

Share

COinS
 
Aug 10th, 12:00 AM

Towards a Medical Tricorder: Defining medical conditions for consumer self-care with focus on non-invasive technologies

This paper investigates the technological readiness of consumer electronics for the measurement of vital signs, cardiovascular / metabolic and infectious diseases and shows how these technologies can promote self-care of consumers. We propose a 3-dimensional framework which characterizes diseases according to their burden of disease, their potential for self-care and the readiness of enabling technologies in consumer devices. With the evaluation of current technologies we show that a growing number of medical conditions, especially lifestyle-related cardiovascular diseases, can be identified and monitored easily, precisely and non-invasively by consumers. Based on a 3D-self-care framework we propose strategies for three target groups: Consumers should focus on lifestyle-related diseases, healthcare payers should focus on research funding for technologies addressing high burden diseases and technology developers should focus on diseases that can be supported by close-to-market technolog